Alemtuzumab appears to be associated with a lower incidence of acute rejection and infection compared with rabbit anti-thymocyte globulin (rATG) induction in kidney and pancreas transplant patients, regardless of age or ethnicity.
The Montreal Cognitive Assessment (MoCA), a rapid screening test for mild cognitive dysfunction, has been shown to correlate with measures of brain atrophy in patients with Alzheimer's disease.